Group 1171274671


Understanding Nonalcoholic Steatohepatitis (NASH)

Nonalcoholic steatohepatitis (NASH) refers to a condition caused by liver inflammation due to fat accumulation resulting in cellular injury. Steatohepatitis is one of the conditions ...
Read More

4 Tips for Managing High Blood Pressure

High blood pressure, also known as hypertension, is commonly referred to as the "silent killer" since the disease can manifest itself without causing any symptoms. ...
Read More

5 Myths About Participating in a Clinical Study

Clinical trials give researchers and scientists the opportunity to learn more about how human bodies function and to test out potentially life-changing new medicines and therapies. ...
Read More

A Beginner’s Guide to Antibody Treatments for COVID

The United States purchased 600,000 additional doses of sotrovimab in the first quarter of 2022 which are to be distributed nationwide. Sotrovimab is an antibody ...
Read More

How Are Monoclonal Antibodies Used in Treating COVID?

Monoclonal antibodies are used to treat COVID 19 through a process known as monoclonal antibody therapy or monoclonal antibody infusion treatment. These are antibodies similar ...
Read More

In The Community

1 (1)

Cullman clinic offers COVID antibody treatment

There is promising news in the fight against COVID-19 in Cullman, an area hit hard during the pandemic.


Monoclonal antibodies ‘the answer’ to Alabama’s COVID surge, doctors say

We witnessed first hand the effectiveness of the Monoclonal Antibody Therapy in subduing the COVID-19 virus. Simply put, these are antibodies made in a lab to help stimulate your body’s defense to the Virus. Very safe and effective treatment.


Orasure Technologies Receives Three Emergency Use Authorizations for Its COVID-19 Rapid Antigen Tests for Non-Prescription (OTC), Professional and Prescription Use

Cullman Clinical Trials staff and volunteers helped make possible!


SAB Biotherapeutics Announces First Patient Dosed in Phase 3 NIH ACTIV-2 Trial Evaluating SAB-185 for Treatment of COVID-19

Being part of cutting-edge and relevant research is not always an easy path but a quite meaningful one. Our heartfelt gratitude goes out to our patients and staff for their participation and hard work!

Screen Shot 2022-03-30 at 2.44.52 PM

Clinical trial for COVID-19 treatment begins in Cullman, participants needed

One of the latest clinical trials is happening in Cullman.


GSK and Vir Biotechnology announce submission of Emergency Use Authorization request to FDA for VIR-7831 for the early treatment of COVID-19

The Monoclonal Antibody made by VIR that we were working on just got Emergency Use Authorization by the FDA.

Become A Paid Participant